CULTIVATION IN PORTUGAL

Our plans to cultivate in the near future





By deciding to produce medical cannabis by ourselves, we can ensure that our flowers and extracts meet our high medical and therapeutic standards. With the granted cultivation permit issued by the Portuguese health authority INFARMED, as well as the forthcoming EU-GACP and EU-GMP certification, we will be able to deliver high quality cannabis products.

Our Story


Present

Through our subsidiary IberCanPharma, we own a licence to grow, manufacture, process and export medical cannabis products. A cannabis plantage of 5 hectares is planned to be built in Almada, Portugal. As we will grow in a total of 40 greenhouse bays, we can take full advantage of the high amount of sunlight in Portugal. Furthermore, we will produce cannabis-extracts. Our complete facility will be EU-GACP and EU-GMP certified.







Past

In response to the growing global demand for cannabis-based medicines, we decided to cultivate, manufacture, process and export medical cannabis. It was important to us that we can control the entire value chain, from the propagation of the strains to the delivery of the product to pharmacies, in order to make sure that our high quality and therapeutic requirements are being met. Under the Portuguese sun we found the perfect conditions to realize our vision.




Future

We will be able to produce and process up to 50 tons of dried cannabis flowers annually to supply licensed wholesalers and research institutes. We expect our first batch of medicinal cannabis products will be available to the markets in the first quarter of 2020. We are looking forward to be one of the leading medical cannabis producers in Europe.




Our Cultivation Process

Fully EU-GMP and GACP certified

The sophisticated cultivation techniques that IberCanPharma is going to use will take place in a greenhouse to ensure a pharmaceutical product that is safe, consistent and of high quality.

Cuttings (Clones) are taken from the mother plant and moved into the propagation area for rooting. 5-8 days later the clones are rooted and young plants now. They will stay in the propagation area for additional 10 days under long day lighting. Afterwards the young plants are carried into the growing rooms. The plants are growing in these rooms for 8-9 weeks. At harvest, Staff will cut of the stem at the base of the plant. After that, the processing supervisor will inspect randoms plants to make sure they are free of pesticides and diseases and the processing team will start processing the plants, separating leaves, stems and flowers. The flowers are also trimmed before being placed on a drying trolley in the drying room. The drying process should take another 5 to 6 days. During the drying process, the flowers lose 70% -80% of their weight – which is an industry standard.
If the dry product is intended for extraction, then, at this stage, the product will be packaged and shipped to the extraction facility. If it is intended to have dried cannabis flowers, the flowers will be placed in large boxes for curing – this takes about 10 to 15 days. Once the cure is done, the product is weighed and placed in plastic bags, vacuum sealed. If our products pass the final quality tests, they will be stored and ready to be sold and shipped.



Our Extraction Methods

Ethanol and CO2

IberCanPharma will use GMP-certified facilities for the production of medical cannabis extracts. Furthermore, the extraction facilities will meet the required technical and safety regulations given by INFARMED.

Ethanol Extraction
IberCanPharma utilizes a state-of-the-art cold extraction process using cryo ethanol extraction technologies designed to preserve the delicate content of cannabinoids and terpenes and to provide a pure and effective product. The ethanolic extraction method offers high capacity, high production and, efficient extraction of botanical oils without thermal degradation.

CO2 Extraction
IberCanPharma also intends to use subcritical and supercritical CO2 extraction when its plantation is in the maximum potential phase. The system can process up to 50 kg of decarboxylated cannabis per day. Using subcritical and supercritical CO2, the systems offer high capacity and high production operations with fast and efficient extraction of botanical oils without thermal degradation.



Quality Assurance

Fullfiling the highest quality standards

The layout of the premises, the equipment and the entire production process comply with the GMP and GACP guidelines. In addition, the quality control will be accompanied by a pharmaceutical quality management and a quality risk management, in order patients can rely on a product, which is of high quality.



Participation in R&D Projects

IberCanPharma is involved in various Research& Development Projects, with the aim to constantly improve its product-portfolio.

Do you have any questions?

Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.

MEMBER OF

footerlogos

OFFICES

CanPharma GmbH
Wiesbadener Str. 29
16515 Oranienburg
Germany

IberCanPharma LDA
Rua João Fernandes
Lavrador 1 – Sala 6 2825-
132 Vila Nova de Caparica
Portugal

REPRESENTATIVE OFFICES

Berlin
Neue Kantstraße 18
14057 Berlin
Germany

Barcelona
Gran de Gràcia 15, 1-1
08012 Barcelona
Spain